Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Clinical Lab Management » NY State Labs Get FDA Emergency Use Authorization for SARS-CoV-2 Test

NY State Labs Get FDA Emergency Use Authorization for SARS-CoV-2 Test

Mar 02, 2020
|
staff reporter

NEW YORK – Two public health labs in New York state have been granted emergency use authorization to run an assay to detect SARS-CoV-2, the pathogen that causes coronavirus disease, or COVID-19. The test was approved according to new emergency diagnostic regulations.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Memo Roll Back

Science reports that a new White House Office of Management and Budget memo rescinds previous ones that helped research institutions deal with pandemic-related closures.

Great, Now a Swine Flu Strain

Researchers report on a concerning strain of the H1N1 swine flu virus found among pigs in China, Agence France Presse reports.

Samples All Together

The Associated Press reports that US officials are considering allowing pooled COVID-19 testing.

Genome Research Studies Explore Y Chromosome Expression, Mutations From Aging Macaque Dads, More

In Genome Research this week: Y chromosome gene expression analysis, de novo mutations rise with paternal age in rhesus macaques, and more.

Jul
15
Featured Webinar

Diagnostic Challenges in Cancer Immunotherapy: An Expert Panel Discussion

Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.

Jul
16
Featured Webinar

Exploring Tumor Tissue Architecture and Immune Response with Digital Spatial Profiling

Sponsored by
NanoString

Join this webinar to learn how spatial resolution of gene expression in tumor tissue reveals new insights in biomarker discovery and therapeutic response. 

Jul
23
Featured Webinar

Clinical Utility of Liquid Biopsy for the Detection of T790M to Guide Lung Cancer Treatment Strategy

Sponsored by
Roche

This webinar will discuss a study that set to assess the efficacy and safety of osimertinib in EGFR T790M positive non-small cell lung cancer (NSCLC) patients identified by using plasma sample and cobas EGFR Mutation test v2. This is the first prospective study to use liquid biopsy upfront to evaluate osimertinib efficacy.

Aug
25
Featured Webinar

Liquid Biopsy-based Molecular Risk Stratification of ALK-mutated Lung Cancer Patients

Sponsored by
Roche

Non-small cell lung cancer (NSCLC) patients with ALK rearrangements are treated with tyrosine kinase inhibitors (TKIs), which often leads to prolonged overall survival. However, treatment resistance will almost inevitably occur, and the disease remains incurable.

What's Popular?

In PCR

  1. FDA Grants EUAs for PCR Coronavirus Tests, Nasal Swab Self-Collection Kit

  2. T2 Biosystems Preliminary Q2 Revenues Up About 40 Percent; Firm Launches COVID-19 Test

  3. Hologic Upgraded to Outperform by Cowen on Expected Coronavirus Test Demand

  4. Iowa Startup FBB Biomed Pursues RNA Blood Test to Predict COVID-19 Disease Severity

    Premium

  5. Fluxergy, Mass General Brigham Partner to Evaluate Rapid COVID-19 Molecular Testing System

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.